TriSalus Life Sciences, Inc. (TLSI) Net income 2021–2025
TriSalus Life Sciences, Inc. (TLSI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$39.2MFY2025 · since FY2021: $4.8M → -$39.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$39.2M | -30.6% |
| FY2024 | -$30.0M | +49.4% |
| FY2023 | -$59.4M | -25.8% |
| FY2022 | -$47.2M | -1089.8% |
| FY2021 | $4.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSI financial trends
TLSI RevenueTLSI Net marginTLSI Gross profitTLSI Gross marginTLSI Operating incomeTLSI Operating marginTLSI Operating cash flowTLSI Free cash flowTLSI Capital expendituresTLSI Return on equityTLSI Stock buybacksTLSI Dividends paidTLSI Total assetsTLSI Total liabilitiesTLSI Shareholders’ equityTLSI overview →